Influenza viral infection in the respiratory system—potential ways of monitoring

Chapter 2

Influenza viral infection in the respiratory system—potential ways of monitoring

S.C.B. Gopinath*,**

T. Lakshmipriya*

U. Hashim*

M.K. Md Arshad*

R.M. Ayub*

T. Adam*,
*    Universiti Malaysia Perlis, Institute of Nano Electronic Engineering (INEE), Kangar, Perlis, Malaysia
**    Universiti Malaysia Perlis, School of Bioprocess Engineering, Arau, Perlis, Malaysia
    Universiti Malaysia Perlis, School of Electronic Engineering Technology, Faculty of Engineering Technology, Kangar, Perlis, Malaysia


Respiratory disease directly affects the lungs and other parts of the body, including the pleural cavity, bronchial tubes, upper respiratory track, and nerves. Viral respiratory disease is mainly caused by viruses such as influenza, respiratory syncytial virus, and adenovirus. Influenza has been focused on in the past as a seasonal disease that is caused by the RNA virus, generally spread via airborne droplets, which easily affects people during breathing and swallowing, and which can become severe. The influenza virus is spherical, enveloped, has a size of ∼100 nm, and it belongs to the family Orthomyxoviridae. During seasonal epidemics, influenza spreads to birds and mammals, which can result in pandemics that cause millions of deaths. The emergence of various types and subtypes of influenza viruses requires effective monitoring strategies to prevent their spread and to develop appropriate antiinfluenza vaccines. A number of different platforms have been proposed to detect influenza viruses. In this chapter, we will review the methods involved in influenza monitoring.



respiratory disease




1. Introduction

Respiratory diseases caused by different viruses usually affect the lung, followed by the trachea and upper part of the respiratory track. Influenza is one of the seasonal RNA viruses that leads to respiratory disease and which spreads easily via airborne droplets. Influenza has three types: Influenza A, B, and C. Among these, A and B are common in humans and C is not common. Influenza virus with ∼100 nm in diameter is formed by different proteins and RNA1,2 (Fig. 2.1). Influenza A and B have eight RNA strands and C has seven. Influenza has been classified by its two major proteins [hemagglutinin (HA) and neuraminidase (NA)] on its surface, which are mainly involved in the multiplication and infection. Until now, 17 HAs (H1–H17) and nine NAs (N1–N9) have been found in different influenza strains. Influenza virus is named according to the number of HA and NA, such as H1N1, H2N2, H3N2, H5N1 and so on.35 Structural studies on these surface proteins elucidate further understanding and help precise classification (Fig. 2.2a,b). New strains of influenza emerge due to seasonal variations, genetic reassortments, the involvement of intermediate hosts, and other environmental influences6,7 (Fig. 2.3). Currently available vaccines cannot prevent the appearance of new strains and, therefore, it is vital to develop novel detection systems to diagnose influenza viruses, which paves the way to generate vaccinations to prevent new influenza viruses.


Figure 2.1 Image of an Intact Influenza Virus
It has a size of about 100 nm in diameter. The major surface proteins are hemagglutinin (HA) and neuraminidase (NA).


Figure 2.2 Crystal Structures of Influenza Surface Proteins
3D structures of Hemagglutinin (HA: PDB Accession: 2VIU) and Neuraminidase (NA: PDB Accession: 3SAL) are displayed.


Figure 2.3 Emergence of Influenza Viruses
Different influenza pandemics are indicated. Influenza hosts are displayed.

Currently, in most cases the antibody-based probes that are predominantly used for influenza virus detection5,8 cannot differentiate among influenza subtypes. Other probes such as aptamer and glycan have been developed to take a step to distinguish influenza subtypes.3,916 These probes have allowed several sensing strategies to be generated from laboratory to industrial scale, and which connects the gap between the different scales.16 On the other hand, in nanotechnology top-down and bottom-up approaches have been used to develop the current plaforms.1723 Currently, the primary aim of sensors is to bring the bench-top sensors to the front-line of medical practitioners. In this chapter, we will discuss the different strategies involved in the detection of influenza disease with novel sensing methods.

2. Probes involved in influenza detection

As stated earlier, the choice of probe (antibody, aptamer, and glycan) is the important factor in the development of sensors for the diagnosis of influenza (Fig. 2.4a–c). These probes have been generated for influenza viruses having higher affinities to the surface proteins (Hemagglutinin-HA; neuraminidase-NA), and they facilitate the whole virus detection. These probes can also be generated for proteins residing inside the virus, such as structural proteins, and in this case the virus has to lyse before being diagnosed. Both antibody and aptamer bind, based on affinities to the target, whereas glycan has both affinity and functional interaction to the target/host cell. Usually, in most viruses glycan mediates the infection, which helps to attach to the host cells. During infection or interaction, the HA of influenza will interact with the glycan present on the host cell.24 After multiplication of viral particles, NA cleaves these glycans (sialic acids) to infect neighboring cells.


Figure 2.4 Probes used for influenza detection
(a) Antibody as probe, (b) aptamer as probe, and (c) glycan as probe. Sialic acids are shown for glycan-based probes α-2,6 and α-2,3.

2.1. Influenza detection by antibody

Antibodies can be generated by injecting the antigen of interest into the animal or a recombinant antibody can be prepared using the DNA sequence of the antigen. Several sensing systems have been demonstrated for influenza using suitable antiinfluenza antibodies. The binding of the antibody and the target (antigen) from the influenza virus generates a signal that can be used to identify the influenza viruses. As stated above, to detect a whole influenza virus, the antigen should be either hemagglutinin or neuraminidase (Fig. 2.2). Gopinath et al.4,5 used HA antibody to detect the influenza viruses and discriminated between HA of human and bird influenza viruses. Again in the case of anti-HA antibody, this can be either anti-HA1 or anti-HA2 antibodies. Researchers have used enzyme linked immunosorbent assay (ELISA) to detect influenza viruses with the HA1 antibodies. In most cases, using antibodies means that we can only differentiate types of influenza viruses. Because of its larger size, in several cases we cannot differentiate subtypes. To substitute antibodies, researchers are currently looking at using aptamers as a probe to detect and differentiate influenza viruses.

2.2. Influenza detection by aptamer

Aptamer is an artificial chemical antibody that is generated from the randomized nucleic acid library by three simple steps: binding, separation, and amplification. The selected aptamer has a high binding affinity with the target molecule.2530 In most cases, aptamer was found to be better than antibodies. Additionally, aptamers have more advantages, such as being easy to prepare, having no variation with different preparations, higher sensitive, they are easy to modify, and they are nonimmunogenic. In the past, several generated aptamers against influenza viruses have been reported to have high affinity. Moreover, since aptamer binds with only a few bases on the target molecule, it has a higher chance to differentiate subtypes of influenza viruses. Among the different target/antigens from influenza viruses, HA is a suitable target for designing the detection strategy because of its high abundance (Fig. 2.4b). HA accounts for 80% of the influenza surface proteins; next to HA, NA molecules are higher in number on influenza surface. Gopinath et al.10,11 have selected the aptamers against both influenza A (H3N2) and B (Johannesburg) viruses, using either HA or whole virus. The same team also generated the aptamer against H1N1; the selected aptamer has a high binding affinity with the HA protein.14 Lakshmipriya et al.31 have selected the aptamers that can be used against intact influenza B virus (B/Tokio) and HA protein of influenza B virus (B/Jilin).

2.3. Influenza detection by glycan

The initiation of viral infection is highly dependent on the presence of receptor molecules on the host cells and it is mediated predominantly by either α-2,6 or α-2,3 linked sialic acid (glycan) chains in human and bird (avian) influenza, respectively32 (Fig. 2.4c). However, following the emergence of different strains in the past several decades, the specificities of these glycans have become varied. Some exceptional cases have been reported, irrespective of glycan specificities, due to special viral adaptations. Furthermore, the avian influenza virus could also infect humans when a close physical touch between human and bird occurred. Different amino acids from the HA protein have been found to be specifically involved in the host interaction. Different sensing strategies have previously been formulated based on glycan to diagnose and discriminate influenza viruses.33,34 The main advantage of sialic acid based sensing is to discriminate avian and human influenza viruses.

3. Detection of Influenza virus

3.1. Immunochromatographic test

Using the above probes, several sensing methods have been reported and have achieved different levels by both qualitative and quantitative detection. With qualitative detection, immunochromatographic test (ICT) has been demonstrated to be reliable. ICT operates based on the lateral flow of solutions, with different set-ups of pad. This system immobilized with gold nanoparticle (GNP)-conjugated antiinfluenza antibody. Upon the interaction of the GNP-conjugated antibody and influenza virus, there will be an accumulation of this complex, which causes the appearance of red colored lines that indicate an influenza positive sample. At the same time, it displays a control red-line and no color formation with a negative line (influenza A or B), depending on the samples to be analyzed (Fig. 2.5). However, this system does not predominantly demonstrate for subtyping (within influenza A or B) purposes. Furthermore, physicians have claimed that ICT can only detect influenza when the patient has attained a high fever. This means that it could not detect an influenza virus in the earlier stages and it needs the higher viral count that happens with the on-set of high fever. Even though ICT has been successful in several instances, for quantitative analyses it is necessary to look for established sensors. The following section will discuss sensors that can detect the target from influenza virus in a quantitative manner.


Figure 2.5 Immunochromatography Test
This is a lateral flow system operating based on different pads. It uses antiinfluenza antibodies conjugated with gold nanoparticles.

3.2. Surface plasmon resonance

Surface Plasmon Resonance (SPR) is the favorite sensor system to analyze biomolecular interactions on the sensing surface in the lower femtomolar range. In an SPR system, light hits a prism and the substrate is then reflected. The angle of the reflected light will be changed depending on the molecules binding on the substrate. Changes in the reflection are considered as the real binding of the ligand and analyte. Using the SPR based principle, various kinds of sensor have been proposed to detect the target against its appropriate partner, such as antibody or aptamer. Among SPR based sensors, BIACORE is the most well established sensing system and it is used to detect biomolecules with higher sensitivity. In the BIACORE system, various sensing surfaces are readily available. Basically, the entire gold surface in this system was modified with different linkers, which are suited for different biomolecular interactive analyses. Using the BIACORE system, Gopinath and colleagues have analyzed the interactions of influenza and aptamers in several different studies with human influenza A viruses.10,11,14,33 With these aptamers, they could reach a picomolar level sensitivity during analysis of influenza belonging to H3N2 and influenza B. With a further step, they attained a femtomolar level sensitivity during analysis of aptamer and H1N1 (swine flu) virus. Similarly, Suenaga et al. have made different studies with avian influenza viruses on SPR.3437

3.3. Surface plasmon fluorescence spectroscopy

Surface plasmon resonance fluorescence spectroscopy (SPFS) works on a similar principle to SPR, the only difference is that SPFS uses fluorescence to detect the analyte. Lakshmipriya et al.31 have detected intact influenza B virus and HA protein of influenza B using SPFS by their appropriate aptamer or antibody. They compared the interaction between antibody and aptamer against influenza viruses and showed an improved detection level. Furthermore, they found that aptamer behaves better than antibody and that it could discriminate influenza types and subtypes. Comparative studies between SPFS and radio isotope labeling revealed the better performance of SPFS. The authors attested to the higher success rate of the operation of SPR, SPFS, and other similar systems, such as waveguide mode sensors, which are is based on Kretschmann configuration.

3.4. Waveguide mode sensor

A waveguide mode sensor is used to detect analyte molecules in a solution and has been used to diagnose influenza virus. Even though the principles of SPR and a waveguide mode sensor are similar, in the waveguide mode system the light that hits the prism passes through the surface as a guiding mode and not as a surface mode.38,39 Depending on the molecular binding on the substrate environment, the reflected light will be changed, and changes in the reflection are considered as the real binding. Gopinath et al.10,11 have demonstrated the use of the binding events for the detection of an influenza virus against antiinfluenza antibody. In their study, they used an antibody raised in the laboratory against H3N2 influenza and had better discriminating ability than commercial antiinfluenza antibody. This anti-H3N2 antibody is able to discriminate types and subtypes of influenza viruses among H3N2, H1N1, and influenza B. To improve the sensitivity of their waveguide mode sensor, they conjugated GNP on the surface of influenza viruses. They were able to attain a sensitivity level of 8 × 103 PFU/mL. They also demonstrated waveguide mode detection of influenza in the absence of GNP and in the presence of dye materials.40

3.5. Gold nanoparticle based colorimetric assay

GNP-based colorimetric assay has been formulated to detect different kinds of molecule with the naked eye. This assay is more suitable for controlled assembly and disassembly of aptamers or antibodies on the GNP in the presence (or absence) of target molecules. Gold has naturally no charge, but GNP will get a surface charge, which may be either positive or negative charge depending on the reagents that are used. Prepared GNP is usually in a dispersed condition (red colored solution) and when we add charged ions they induce aggregation (blue/purple-colored solution).19 Usually monovalent or divalent ions can be used to induce the aggregation. Sodium chloride (NaCl) has predominantly been used to induce the aggregation. When aptamer or antibody is used with dispersed GNP, it keeps the same status (dispersed red solution), even in the presence of NaCl, and the aptamer/antibody will bind to GNP by electrostatic interaction or chemical reaction. However, in the presence of appropriate target molecules to the aptamer/antibody, GNP will be aggregated (blue solution) in the presence of NaCl. Under this condition, a complex of aptamer/antibody target will be formed and this will induce the aggregation. Lee et al.41 have developed a colorimetric assay for influenza detection, they used glycan (sialic acid) as the probe and reached a sensitivity of up to 512 HA titer (for influenza B/Victoria and B/Yamagata). In this case, the assay is slightly modified, but this is not like controlled assembly and disassembly. They formulated that in the presence of influenza virus, the complex will be formed with sialic acid-conjugated GNP and this will induce virus mediated aggregation. Gopinath et al.19 have revealed the nonfouling effect of HA protein on the GNP and they compared their results with other molecules.

3.6. Disc platform—interferometry

As mentioned above, sensing platforms have been reported to be appropriate systems for detection of influenza virus and other molecules. However, most of the sensing designs are suitable for analyzing a limited number of samples. A sensing platform/system suitable for high-throughput screening with the facility to analyze higher number of samples is highly appreciated. The disc platform is suitable for high-throughput sampling. The disc platform is basically designed based on a commercial compact disc (CD) or digital versatile disc (DVD). Varma et al.42 have shown CD-based detections of biomolecules with antigen–antibody interactions. Later, Gopinath et al.4345 have shown the progression with the DVD platform and analyzed different samples, including influenza viruses. These two platforms have spiral tracks on the surface that can accommodate several thousands of samples. The cost of the sensing surface is cheaper and easier for surface functionalization. In most cases, gold was used as the top substrate layer and it can be easily linked to biomolecules through thiol groups. Gopinath et al.44 have used five layer structures, with a top gold layer, for biomolecular interactive analyses. For the interactive analysis of influenza virus-A against its antibody, they attained a dissociation constant to the lower nanomolar level. This level is comparable to the detection level of BIACORE with the same molecules.

3.7. Fluorescent capturing

In most cases, these platforms are defined as label-free, except for SPFS. However, other fluorescent labelling techniques are also used for the diagnosis of influenza. For example, fluorescent labelling has the advantage of higher sensitivity, although it has been argued that it is difficult to label the molecule due to the unavailability of the site for labelling or because the labelling site may be hidden. Several different labelling materials, such as rhodamine, cyanine, Alexa Flour, and fluorescein, are routinely used for different bio-labelling strategies (Fig. 2.6a,b). In the SPFS method for influenza virus detection, Lakshmipriya et al.31 used cyanine as the fluorescent material to label the aptamer. Nomura et al.8 used Alexa Flour 700 for the detection of influenza virus. They used a new kind of SPR system without involving the use of a prism (prism-free). A CCD camera system has been used to capture the fluorescent signaling upon interaction of influenza virus and antiinfluenza H3N2 antibody. With this system, the authors have shown a clear discrimination between influenza subtypes using antibody.


Figure 2.6 Fluorescent-Based Detection Strategies
(a) Aptamer-conjugated fluorescent; (b) antibody-conjugated fluorescent; (i–iii) different ways of detection.

3.8. Enzyme linked immunosorbent assay

ELISA is the gold standard method to detect a wide range of target molecules assisted with appropriate partner molecules. ELISA is used not only for the detection but also for the basic screening of many important diseases, such as HIV, influenza, and so on. Gopinath et al.14 have demonstrated ELISA based detection of influenza virus using anti-H3N2 antibody and discriminated against other influenza viruses. Due to its high sensitivity and selectivity, ELISA helps to identify the target molecules, even in the human crude samples (serum, urine, and saliva). Until now, antibodies have commonly been used as a probe to detect biomolecules in ELISA. In general, the binding of the target (antigen) and the probe (antibody) on the ELISA plate was detected by the enzyme (eg, horseradish peroxidase (HRP), alkaline phosphatase) conjugated with a secondary antibody and detected by chromogenic substrates. Biotin-streptavidin conjugation has also been used to improve the ELISA methods. In this case, biotinylated secondary antibody was detected by streptavidin-conjugated enzyme. Various kinds of pattern are used in the ELISA method to improve the detection methods, such as direct, indirect, sandwich, and competitive ELISA. In most of the cases, antibody was used as the probe due its strong binding, stability, and selectivity. The sandwich ELISA is usually conducted by the monoclonal or polyclonal antibody of the specific target (Fig. 2.7). In some cases, only the Fc region of the antibody has been used as the capture molecule on the ELISA plate. After aptamer generation, some researchers have used aptamer as the probe instead of antibody. This method is called aptamer linked immunosorbent assay (ALISA).46 Since aptamer has a higher sensitivity than the antibody, it is possible to increase the limit of detection when aptamer is used as the probe. In addition, there is a possibility to do a sandwich assay with two different aptamers for the same target. Since both aptamer and antibody are suitable as detection molecules, there is a higher possibility of increasing the limit of detection with the sandwich patterns using aptamer and antibody.


Figure 2.7 Enzyme Linked Immunosorbent Assay (ELISA)
There are basically three types of ELISAs (direct, indirect, and sandwich). Here a sandwich ELISA is shown as an example.

4. Conclusions

Currently, the treatment for influenza is focused against the neuraminidase protein, which is one of the major proteins on the surface of the influenza virus, by a so called drug “Tamiflu.” Current vaccines cannot prevent all types of influenza viruses because current vaccination is only suitable for particular influenza viruses, while every year different subtypes of influenza viruses are emerging. Therefore, it is necessary to generate a new vaccine, and a good starting point for this purpose is to diagnose new influenza strains and generate an efficient detection system that is suitable for early diagnosis. Moreover, the use of currently available antibodies does not allow us to create a detection system which can distinguish influenza subtypes. Development of a complement detection system which uses different molecules, such as antibody with aptamer, aptamer with glycan or glycan with antibody, will increase the possibility of developing novel detection systems. Further optimization of studies performed with viruses/molecules other than influenza viruses can be coupled for influenza detection strategies.4752


1. Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng RH, Kawaoka Y. Architecture of ribonucleo-protein complexes in influenza a virus particles. Nature. 2006;439:490492.

2. Shima T, Fujimaki M, Yoshida A, Gopinath SCB, Kuwahara M, Ohki Y, Awazu K. Detection of influenza viruses attached to an optical disk. J Biomat Nanobiotechnol. 2013;4:145150.

3. Gopinath SCB. Anti-viral aptamers. Arch Virol. 2007;152:21372157.

4. Gopinath SCB, Awazu K, Fujimaki M, Shimizu K, Shima T. Observations of immuno-gold conjugates on influenza viruses using waveguide-mode sensor. PLoS One. 2013;8:e69121.

5. Gopinath SCB, Awazu K, Fujimaki M, Shimizu K. Evaluation of Anti-A/Udorn/307/1972 antibody specificity to Influenza viruses using a waveguide mode sensor. PLoS One. 2013;8:e81396.

6. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152179.

7. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine- origin H1N1 influenza virus. Nature. 2009;459:931939.

8. Nomura K, Gopinath SCB, Lakshmipriya T, Fukuda N, Wang X, Fujimaki M. An angular fluidic channel for prism-free surface-plasmon-assisted fluorescence capturing. Nat Commun. 2013;4:2855.

9. Jeon SH, Kayhan B, Ben-Yedidia T, Arnon R. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. J Biol Chem. 2004;279:4841048419.

10. Gopinath SCB, Misono TS, Kawasaki K, Mizuno M, Imai T, Odagiri T, Kumar PKR. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits hemagglutinin-mediated membrane fusion. J Gen Virol. 2006;87:479487.

11. Gopinath SCB, Sakamaki Y, Kawasaki K, Kumar PKR. An efficient RNA aptamer against human influenza B virus hemagglutinin. J Biochem. 2006;139:837846.

12. Gopinath SCB, Awazu K, Fujimaki M. Waveguide-mode sensors as aptasensors. Sensors. 2012;12:21362151.

13. Gopinath SCB, Tang TH, Yeng C, Citartan M, Tominaga J, Lakshmipriya T. Sensing strategies for influenza surveillance. Biosens Bioelectron. 2014;61:357369.

14. Gopinath SCB, Kumar PKR. Aptamers that bind to the hemagglutinin of recent pandemic H1N1 and inhibits efficiently the agglutination. Acta Biomaterialia. 2013;9:89328941.

15. Hidari KIPJ, Suzuki T. Glycan receptor for influenza virus. Open Antimicrob Agents J. 2010;2:2633.

16. Fathil MF, Md Arshad MK, Gopinath SC, Hashim U, Adzhri R, Ayub RM, Ruslinda AR, Nuzaihan MNM, Azman AH, Zaki M, Tang TH. Diagnostics on acute myocardial infarction: cardiac troponin biomarkers. Biosens Bioelectron. 2015;70:209220.

17. Yuan Y, Gopinath SCB, Kumar PKR. Regeneration of commercial Biacore chips to analyze biomolecular interactions. Opt Engg. 2011;50: 034402-1-6.

18. Perumal V, Hashim U, Gopinath SCB, Haarindraprasad R, Ravichandran M, Balakrishnan SR, Poopalan P. A new nano-worm structure from gold-nanoparticle mediated random curving of zinc oxide nanorod. Biosens Bioelectron. 2016;78:1422.

19. Gopinath SCB, Lakshmipriya T, Awazu K. Colorimetric detection of controlled assembly and disassembly of aptamers on unmodified gold nanoparticles. Biosen Bioelectron. 2014;51:115123.

20. Haarindraprasad R, Hashim U, Gopinath SCB, Kashif M, Veeradasan P, Balakrishnan SR, Foo KL. Low temperature annealed zinc oxide nanostructured thin film-based transducer: characterization for sensing applications. PloS One. 2015;10:e0132755.

21. Perumal V, Hashim U, Gopinath SCB, Haarindraprasad R, Foo KL, Balakrishnan SR, Poopalan P. ‘Spotted nanoflowers’-gold-seeded zinc oxide nanohybrid for selective bio-capture. Sci Rep. 2015;5:12231.

22. Balakrishnan SR, Hashim U, Gopinath SCB, Poobalan P, Hariram R, Omar I, Dhahi TS, Haarindraprasad R, Veeradasan P. Polysilicon nanogap lab-on-a-chip: a point-of-care immunosensing human chorionic gonadotropin in clinical human urine. Plos One. 2015;10:e0137891.

23. Nadzirah Sh, Azizah N, Hashim U, Gopinath SCB, Kashif M. Titanium dioxide nanoparticle-based interdigitated electrodes: a novel current to voltage DNA biosensor recognizes E. coli O157:H7. Plos One. 2015;10:e0139766.

24. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Ann Rev Biochem. 2000;69:531569.

25. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346:818822.

26. Kumarevel T, Gopinath SCB, Nishikawa S, Mizuno H, Kumar PKR. Identification of important chemical groups of the hut mRNA for HutP interactions that regulates the hut operon in Bacillus subtilis. Nucleic Acids Res. 2004;32:39043912.

27. Gopinath SCB, Balasundaresan D, Akitomi J, Mizuno H. An RNA aptamer that discriminates bovine factor IX from human factor IX. J Biochem. 2006;140:667676.

28. Gopinath SCB, Awazu K, Fujimaki M, Sugimoto K, Ohki Y, Komatsubara T, Tominaga J, Gupta KC, Kumar PKR. Influence of nonometric holes on the sensitivity of waveguide plasmon: a label-free nano-sensor to analyze RNA-aptamer ligand interactions. Anal Chem. 2008;80:66026609.

29. Gopinath SCB, Hayashi K, Kumar PKR. Aptamer that binds to the gD protein of herpes simplex virus-1 and efficiently inhibits viral entry. J Virol. 2012;86:67326744.

30. Gopinath SCB. Aptamers. In: Meyers RA, ed. Encyclopedia of analytical chemistry. Chichester: John Wiley; 2011:93120.

31. Lakshmipriya T, Fujimaki M, Gopinath SCB, Awazu K. Generation of anti-influenza Aptamers using systematic evolution of ligands by exponential enrichment for sensing applications. Langmuir. 2013;29:1510715115.

32. Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bulletin. 2005;28:399408.

33. Gopinath SCB, Awazu K, Fujimaki M. Detection of influenza viruses by a waveguide-mode sensor. Anal Method. 2010;2:18801884.

34. Suenaga E, Kumar PKR. An aptamer that binds efficiently to the hemagglutinins of highly pathogenic avian influenza viruses (H5N1 and H7N7) and inhibits hemagglutinin–glycan interactions. Acta Biomaterialia. 2014;10:13141323.

35. Suenaga E, Mizuno H, Kumar PKR. Monitoring influenza hemagglutinin and glycan interactions using surface plasmon resonance. Biosens Bioelectron. 2012;32:195201.

36. Gopinath SCB, Awazu K, Fujimaki M, Shimizu K. Neu5Acα2,6Gal and Neu5Acα2,3Gal receptor specificities on influenza viruses determined by a waveguide-mode sensor. Acta Biomaterialia. 2013;9:50805087.

37. Suenaga E, Mizuno H, Kumar PKR. Influenza virus surveillance using surface plasmon resonance. Virulence. 2012;3:464470.

38. Gopinath SCB, Misono T, Kumar PKR. Prospects of ligand-induced aptamers. Crit Rev Anal Chem. 2008;38:3447.

39. Fujimaki M, Nomura K, Sato K, Kato T, Gopinath SCB, Wang X, Awazu K, Ohki Y. Detection of coloured nanomaterials using evanescent field-based waveguide sensors. Opt Exp. 2010;18:1573215740.

40. Gopinath SCB, Awazu K, Fujimaki M, Sugimoto K, Ohki Y, Komatsubara T, Tominaga J, Kumar PKR. Monitoring surface-assisted biomolecular assembly by means of evanescent-field-coupled waveguide-mode nanobiosensors. Anal Bioanal Chem. 2009;394:481488.

41. Lee C, Gaston MA, Weiss AA, Zhang P. Colorimetric viral detection based on sialic acid stabilized gold nanoparticles. Biosens Bioelectron. 2013;42:236241.

42. Varma MM, Nolte DD, Inerowicz HD, Regnier FE. Spinning-disk self-referencing interferometry of antigen–antibody recognition. Opt Lett. 2004;29:950952.

43. Gopinath SCB, Awazu K, Kumar PKR, Tominaga J. Monitoring biomolecular interactions on a digital versatile disc: a BioDVD platform technology. ACS Nano. 2008;2:18851895.

44. Gopinath SCB, Awazu K, Fons P, Tominaga J, Kumar PKR. A sensitive multilayered structure suitable for biosensing on the BioDVD platform. Anal Chem. 2009;81:49634970.

45. Gopinath SCB, Kumar PKR, Tominaga J. A BioDVD media with multilayered structure is suitable for analyzing biomolecular interactions. J Nanosci Nanotechnol. 2011;11:56825688.

46. Toh SY, Citartan M, Gopinath SCB, Tang TH. Aptamer as a modular replacement of antibodies in enzyme-linked immunosorbent assay. Biosens Bioelectron. 2015;64:392403.

47. Anbu P, Gopinath SCB, Hilda A, Mathivanan N, Annadurai G. Secretion of keratinolytic enzymes and keratinolysis by Scopulariopsis brevicaulis and Trichophyton mentagrophytes: regression analysis. Canadian J Microbiol. 2006;52:10601069.

48. Gopinath SCB, Shikamoto Y, Mizuno H, Kumar PKR. Snake venom-derived factor IX binding protein specifically blocks the Gla domain-mediated-membrane binding of human factors IX and X. Biocheml J. 2007;405:351357.

49. Gopinath SCB, Anbu P, Lakshmipriya T, Hilda A. Strategies to characterize fungal lipases. BioMed Res Int. 2013;2013: ID 154549.

50. Poongodi GL, Suresh N, Gopinath SCB, Chang T, Inoue S, Inoue Y. Dynamic change of NCAM polysialylation on human neuroblastoma (IMR-32) and rat pheochromocytoma (PC-12) cells during growth and differentiation. J Biol Chem. 2002;277:2820028211.

51. Gopinath SCB. Anti-coagulant aptamers. Thromb Res. 2008;122:838847.

52. Gopinath SCB, Hilda A, Lakshmipriya T, Annadurai G, Anbu P. Purification of lipase from Geotrichum candidum: conditions optimized for enzyme production using Box-Behnken design. World Microbiol Biotechnol. 2003;19:681689.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Dec 14, 2017 | Posted by in MICROBIOLOGY | Comments Off on Influenza viral infection in the respiratory system—potential ways of monitoring

Full access? Get Clinical Tree

Get Clinical Tree app for offline access